Feed UTI
UT

Universal Technical Institute

UTI · NYSE

$21.47 +3.12% (+$0.65)
1M -3.94%
Market Cap $1.15B
P/E Ratio 33.44x
Div. Yield -
ROE 10.17%

Bulios Fair Price

$14.5

32.5% downside

Current Price

$21.47

Undervalued Fair Value Overvalued

According to Bulios Fair Price, UTI is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
6/9
Valuation
66 /100
Fair
EV/EBITDA 13.16x
P/S 1.30x
P/B 3.33x
Growth
100 /100
Growing
Rev. growth 25.90%
Book val. growth 15.06%
EPS growth 43.80%
Profitability
32 /100
Weak
Net margin 3.88%
Op. margin 5.01%
FCF margin 2.59%
Quality
41 /100
Average
ROE 10.17%
ROA 3.82%
Asset turnover 0.98x
Debt
61 /100
Moderate
Current ratio 1.30x
Int. coverage 12.01x
Net debt/EBITDA 2.19x
Stability
39 /100
Moderate
Rev. volatility 16.33%
EPS volatility 285.71%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about UTI
Online

Sector

Consumer Defensive

Industry

Education & Training Services

CEO

Jerome A. Grant

Employees

4,100

Headquarters

Phoenix

Upcoming events

18 NOV

Earnings

Upcoming earnings report

59d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.